Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemia (opens in a new tab)
Blood Cancer J
Primary practice
Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma
Find Dr. Scheckel's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Scheckel practices at Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma.
Dr. Scheckel's NPI, 1447606348, was assigned on May 10, 2016. Dr. Scheckel graduated from Oklahoma State University College of Osteopathic Medicine in 2016. Dr. Scheckel holds Oklahoma license 7579.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Scheckel's primary practice is Oklahoma Cancer Specialists and Research Institute, at 12697 E 51st St, Tulsa, OK 74146 in Tulsa County. The practice phone is (918) 505-3200.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Scheckel's primary practice is Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma. Dr. Scheckel is also affiliated with Ascension St. John Medical Center. The medical group on file is Oklahoma Cancer Specialists and Research Institute. Dmand AI also links Dr. Scheckel to 4 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Scheckel practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Oklahoma Cancer Specialists and Research Institute | Available with a free account |
| +6 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Hematology and oncology is Dr. Scheckel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Scheckel's licenses on file in 3 states: Oklahoma, Arizona and Minnesota.
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
CMS data shows 120,330 Medicare services from Dr. Scheckel across 86 procedure codes in 2024, for 821 Medicare patients. Medicare paid $1,863,464 for them.
Medians across 124 hematologists and oncologists in Oklahoma with Dmand AI profiles that report each measure.
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Scheckel?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Scheckel and other hematologists and oncologists in Oklahoma.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
CMS counts 821 Medicare patients who saw Dr. Scheckel in 2024. The largest group is 65 to 74, with 382 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 6% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Scheckel's median patient age at 72, with 54% women.
Share of Medicare patients with each condition. A patient can have several.
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Median age 72
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
In 2024, Dr. Scheckel wrote 2,026 Medicare Part D claims for 198 patients. 71% of them were for generic drugs. CMS names the drug for 1,746 of them, across 47 drugs with 11 or more claims each, at $6,803,484 in total drug cost. In 2023, CMS named 1,201 claims across 39 drugs.
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Drugs named by CMS: 47 in 2024, 39 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Scheckel for performance year 2024, reported individually. Dr. Scheckel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dmand AI links 26 papers to Dr. Scheckel, published from 2016 to 2023. 2022 was the busiest year, with 4. The most frequent topics are Osteopathic Medicine, Training Support and Career Choice. Dr. Scheckel has published most often in J Am Osteopath Assoc. Dr. Scheckel's most frequent co-authors are Jithma Prasad Abeykoon, MD, Ronald S. Go, MD and Gaurav Goyal.
Topics Dr. Scheckel writes about most
Blood Cancer J
JCO Oncol Pract
Hematol Oncol Clin North Am
JAMA Netw Open
See who Dr. Scheckel researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Scheckel works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
CMS Open Payments shows 167 general payments to Dr. Scheckel from 33 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $51,548.
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Scheckel graduated from Oklahoma State University College of Osteopathic Medicine in 2016.
Source: Dmand AI Professional Profile Data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
Dr. Caleb J. Scheckel's NPI number is 1447606348. It was assigned on May 10, 2016, and it is active in the NPI Registry.
Dr. Caleb J. Scheckel is a hematologist and oncologist in Tulsa, Oklahoma. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Dr. Scheckel practices at 12697 E 51st St, Tulsa, OK 74146. Dr. Scheckel's primary practice is Oklahoma Cancer Specialists and Research Institute in Tulsa, Oklahoma. Dmand AI also links Dr. Scheckel to 4 hospitals and 1 group practice or clinic.
The practice phone on file for Dr. Scheckel is (918) 505-3200.
Dr. Scheckel holds Oklahoma license 7579, one of the licenses on file in 3 states.
Dmand AI has state licenses on file for Dr. Scheckel in Oklahoma, Arizona and Minnesota.
Dr. Scheckel is affiliated with Ascension St. John Medical Center. Dmand AI links Dr. Scheckel to 4 more hospitals.
Dr. Scheckel is linked to Oklahoma Cancer Specialists and Research Institute.
Yes. CMS data shows Dr. Scheckel billed Medicare for 120,330 services in 2024, and Dr. Scheckel accepts Medicare assignment.
Dr. Scheckel's MIPS final score for performance year 2024 is 95 out of 100, reported individually.
CMS counts 821 Medicare patients who saw Dr. Scheckel in 2024, with an average age of 74.
In 2024, Dr. Scheckel's most billed Medicare services were medicare temporary code (Q9967), injected or infused drug (J1439) and injected or infused drug (J9299).
Dr. Scheckel graduated from Oklahoma State University College of Osteopathic Medicine in 2016.
In 2024 Medicare Part D data, Dr. Scheckel's most prescribed drugs by claims were Acyclovir, Revlimid and Sulfamethoxazole-Trimethoprim.
CMS Open Payments shows $159,303 in general payments to Dr. Scheckel from 33 companies from 2022 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
Dr. Scheckel graduated from medical school in 2016, 10 years ago.
Dmand AI links 26 publications to Dr. Scheckel, published from 2016 to 2023.
Dr. Scheckel's most frequent co-authors are Jithma Prasad Abeykoon, MD (2 shared papers), Ronald S. Go, MD (2 shared papers) and Gaurav Goyal (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Oklahoma by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.